Skip to main content
Research project


Project overview

SMILE aims to reduce the disease/treatment-associated side-effect burden in medulloblastoma survivors. This will be achieved by forming a unique multidisciplinary team of internationally-leading experts and future leaders, optimally positioned to initiate a pan-European network for the development/delivery of future clinical advances.


Other researchers

Dr Kim Bull PhD, MSc, BSc (Hons)

Associate Professor

Research interests

  • Quality of survival in children treated for brain tumours within the context of European treatment trials.
  • Health-related quality of life in children treated for brain tumours.
  • Optomising the collection of patient-reported outcomes (PROs) in children treated for brain tumours.
to top